stockrowHarmony Biosciences Holdings, Inc. (HRMY) vs Vir Biotechnology, Inc. (VIR)
- Harmony Biosciences Holdings, Inc. HRMY 33.04 +1.76%
- Vir Biotechnology, Inc. VIR 12.19 +10.62%
Harmony Biosciences Holdings, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. Harmony Biosciences Holdings, Inc. and Vir Biotechnology, Inc. are of similar size ($1.9B and $1.9B). Vir Biotechnology, Inc. has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 10.7×. Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,696.0% against 19.8%. Harmony Biosciences Holdings, Inc. has the higher net margin (18.1% vs −61.0%) and the higher return on invested capital (30.5% vs −30.3%). Across the 18 metrics below, Harmony Biosciences Holdings, Inc. leads on 13 and Vir Biotechnology, Inc. on 5.
Valuation
Profitability
| Metric | HRMY | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.03% | 99.99% | 68.51% |
| Operating margin | 22.17% | (69.82%) | 0.00% |
| Net margin | 18.05% | (61.03%) | 0.00% |
| Free cash flow margin | 32.65% | (46.87%) | 0.00% |
| Return on equity | 18.73% | (21.84%) | (51.96%) |
| Return on assets | 13.30% | (17.34%) | (46.06%) |
| Return on invested capital | 30.45% | (30.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack